ctrl K

AI Score

Unlock

Tarsus Pharmaceuticals In... (TARS)

AI Score

Unlock

48.96

-2.41 (-4.69%)

At close: Apr 01, 2025, 3:59 PM

48.92

-0.08%

After-hours: Apr 01, 2025, 05:17 PM EDT

Tarsus Pharmaceuticals Income Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	182.95M	17.45M	25.82M	57.03M	n/a
Cost of Revenue	12.83M	1.59M	955K	2.08M	246K
Gross Profit	170.13M	15.85M	24.86M	54.95M	-246K
Operating Income	-120.57M	-143.16M	-62.71M	-12.16M	-27M
Interest Income	15.01M	10.34M	3.5M	36K	188K
Pretax Income	-115.55M	-135.89M	-62.09M	-13.77M	-26.81M
Net Income	-115.55M	-135.89M	-62.09M	-13.83M	-26.81M
Selling & General & Admin	237.31M	108.7M	44.95M	25.4M	8.17M
Research & Development	53.39M	50.31M	42.62M	41.71M	18.83M
Other Expenses	n/a	n/a	86K	-73K	n/a
Operating Expenses	290.7M	159.01M	87.57M	67.11M	27M
Interest Expense	7.45M	3.35M	2.2M	n/a	188K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	303.52M	160.6M	88.53M	69.18M	27M
Income Tax	n/a	n/a	-4K	55K	1K
Shares Outstanding (Basic)	37.6M	29.38M	24.62M	20.55M	20.32M
Shares Outstanding (Diluted)	37.6M	29.38M	24.62M	20.55M	20.32M
EPS (Basic)	-3.07	-4.62	-2.52	-0.67	-1.32
EPS (Diluted)	n/a	n/a	n/a	n/a	n/a
EBITDA	-106.88M	-131.67M	-59.11M	-13.17M	-26.56M
Depreciation & Amortization	1.23M	877K	789K	606K	246K